In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs

被引:40
作者
Pradines, B
Tall, A
Fusai, T
Spiegel, A
Hienne, R
Rogier, C
Trape, JF
Le Bras, J
Parzy, D
机构
[1] Serv Sante Armees, Inst Trop Med, Unite Parasitol, F-13998 Marseille, France
[2] Hop Bichat Claude Bernard, Ctr Natl Reference Chimiosensibil Paludisme, F-75877 Paris, France
[3] Inst Pasteur, Serv Epidemiol, Dakar, Senegal
[4] ORSTOM, Lab Paludol, Dakar, Senegal
关键词
D O I
10.1128/AAC.43.2.418
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The 50% inhibitory concentration (IC(50)s) of benflumetol (range, 12.5 to 250 nM; mean, 55.1 nM) for 158 Senegalese isolates were evaluated. Ten isolates (6%) showed decreased susceptibility to benflumetol. Benflumetol was slightly more potent against chloroquine-resistant isolates (P < 0.025). No correlation or weak correlations in the responses to benflumetol and pyrimethamine, chloroquine, amodiaquine, artemether, quinine, and pyronaridine were observed, and these correlations are insufficient to suggest cross-resistance. Benflumetol may be an important alternative drug for the treatment of chloroquine-resistant malaria.
引用
收藏
页码:418 / 420
页数:3
相关论文
共 21 条
[1]  
[Anonymous], 1990, Trans R Soc Trop Med Hyg, V84 Suppl 2, P1
[2]   In vitro activity of lumefantrine (benflumetol) against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon [J].
Basco, LK ;
Bickii, J ;
Ringwald, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2347-2351
[3]   An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials [J].
Dorn, A ;
Vippagunta, SR ;
Matile, H ;
Jaquet, C ;
Vennerstrom, JL ;
Ridley, RG .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (06) :727-736
[4]   ANTIMALARIAL SCHIZONTOCIDES - FERRIPROTOPORPHYRIN-IX INTERACTION HYPOTHESIS [J].
FITCH, CD .
PARASITOLOGY TODAY, 1986, 2 (12) :330-331
[5]   Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years [J].
Hatz, C ;
Abdulla, S ;
Mull, R ;
Schellenberg, D ;
Gathmann, I ;
Kibatala, P ;
Beck, HP ;
Tanner, M ;
Royce, C .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1998, 3 (06) :498-504
[6]  
JELINEK T, 1995, TROP MED PARASITOL, V46, P38
[7]   INDICATORS OF LIFE-THREATENING MALARIA IN AFRICAN CHILDREN [J].
MARSH, K ;
FORSTER, D ;
WARUIRU, C ;
MWANGI, I ;
WINSTANLEY, M ;
MARSH, V ;
NEWTON, C ;
WINSTANLEY, P ;
WARN, P ;
PESHU, N ;
PASVOL, G ;
SNOW, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (21) :1399-1404
[8]  
MOLINIER S, 1994, PRESSE MED, V23, P1494
[9]  
*NOV CO ART INT DE, 1998, INT LAV ASS C, P99
[10]   In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs [J].
Pradines, B ;
Rogier, C ;
Fusai, T ;
Tall, A ;
Trape, JF ;
Doury, JC .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 58 (03) :354-357